Cleared Special

INSUFLOW SYNERGY PORT, INSUFLOW SYNERGY XL PORT (K140263) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K140263 · Lexion Medical, LLC · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
30d
Days
Class 2
Risk

K140263 is an FDA 510(k) clearance for the INSUFLOW SYNERGY PORT, INSUFLOW SYNERGY XL PORT. Classified as Insufflator, Laparoscopic (product code HIF), Class II - Special Controls.

Submitted by Lexion Medical, LLC (St. Paul, US). The FDA issued a Cleared decision on March 5, 2014 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.1730 - the FDA obstetrics and gynecology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Lexion Medical, LLC devices

Submission Details

510(k) Number K140263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 03, 2014
Decision Date March 05, 2014
Days to Decision 30 days
Submission Type Special
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
130d faster than avg
Panel avg: 160d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code HIF Insufflator, Laparoscopic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.1730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - HIF Insufflator, Laparoscopic

All 176
Devices cleared under the same product code (HIF) and FDA review panel - the closest regulatory comparables to K140263.
Insufflator (OPTO-IFL1000)
K252318 · Guangdong Optomedic Technologies, Inc. · Apr 2026
ENDOFLATOR +
K250388 · Karl Storz SE & CO. KG · Sep 2025
AirSurgN Insufflator (10030/AirSurgN)
K242772 · Smartsurgn, Inc. · Apr 2025
High Flow Insufflation Unit (UHI-4)
K243527 · Olympus Medical Systems Corporation · Jan 2025
TauTona Pneumoperitoneum Assist Device (TPAD)
K242536 · Tautona Group · Oct 2024
VereSee Optical Veres Needle System
K232464 · Freyja Healthcare, LLC · May 2024